- Main navigation
- CLIC & The CTSA Program
- News & Events
- Groups
- Common Metrics Initiative
- Education & Career Development
- Team Science & Collaboration
- Resources
- CTSA Program Projects & Initiatives
- Contact
- Search
Session recordings are now available from the DC CTSA Consortium's 2022 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. DAY 1 - LASTING IMPACTS OF THE COVID-19 PANDEMIC (APRIL 28, 2022) - Keynote Address - Transcriptome profiling of human blood as a platform for diagnostic biomarker development: Measure broadly, listen carefully - Panel 1: Long-term COVID-19
Session recordings and slide presentations are now available from the DC CTSA Consortium's 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. Moving Swiftly to Combat the COVID-19 Global Health Crisis (4/23/21) Keynote, featuring David Diemert, MD, FRCP(C) Panel 1: COVID-19 Vaccine Research, Recruitment, and Testing Panel 2: Regulatory Issues Related to
The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators
The DC CTSA Consortium is pleased to announce the 2021 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research. This free, virtual conference will take place on Friday, April 23, 2021, and Friday, April 30, 2021, from 9:30 AM to 12:30 PM EST. Each day will feature keynote presentations and moderated panel discussions. This conference brings researchers, administrators
Myasthenia gravis (MG) is an autoimmune disease that blocks the signal from nerve to muscle, producing weakness. The nature of the disease can range from isolated severe vision problems, like drooping eyelids or double vision, to profound general weakness leading to breathing muscle failure. Although the cause of MG is not known, the disease appears to vary based on several factors, including the
The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis.
This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current landscape of clinical trials. The focus for this meeting was “COVID-19: the Virus, Preparedness in the
This annual meeting brings researchers, administrators, and clinical professionals from throughout the Clinical and Translational Sciences Awards (CTSA) region together for collaborative discussion and response to regulatory revisions and identified clinical research priorities within the current landscape of clinical trials. The focus for this meeting will be on “COVID-19: the Virus, Preparedness